
Suhan Ni
Examiner (ID: 3854)
| Most Active Art Unit | 2656 |
| Art Unit(s) | 2691, 2615, 2643, 2614, 2656, 2651, 2743, 2646 |
| Total Applications | 2030 |
| Issued Applications | 1623 |
| Pending Applications | 153 |
| Abandoned Applications | 292 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4813892
[patent_doc_number] => 20080194523
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-14
[patent_title] => 'Hiv Integrase Inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/997779
[patent_app_country] => US
[patent_app_date] => 2006-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14845
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0194/20080194523.pdf
[firstpage_image] =>[orig_patent_app_number] => 11997779
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/997779 | Hiv Integrase Inhibitors | Jul 27, 2006 | Abandoned |
Array
(
[id] => 5205709
[patent_doc_number] => 20070027191
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-01
[patent_title] => 'Polysubstituted 1,1-pyridyloxycyclopropanamine compounds'
[patent_app_type] => utility
[patent_app_number] => 11/493070
[patent_app_country] => US
[patent_app_date] => 2006-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14351
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0027/20070027191.pdf
[firstpage_image] =>[orig_patent_app_number] => 11493070
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/493070 | Polysubstituted 1,1-pyridyloxycyclopropanamine compounds | Jul 25, 2006 | Issued |
Array
(
[id] => 843715
[patent_doc_number] => 07388022
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-06-17
[patent_title] => 'Polysubstituted 1,1-pyridylaminocyclopropanamine compounds'
[patent_app_type] => utility
[patent_app_number] => 11/493155
[patent_app_country] => US
[patent_app_date] => 2006-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10203
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/388/07388022.pdf
[firstpage_image] =>[orig_patent_app_number] => 11493155
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/493155 | Polysubstituted 1,1-pyridylaminocyclopropanamine compounds | Jul 25, 2006 | Issued |
Array
(
[id] => 9250540
[patent_doc_number] => 08614318
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-12-24
[patent_title] => 'Apoptosis promoters'
[patent_app_type] => utility
[patent_app_number] => 11/491851
[patent_app_country] => US
[patent_app_date] => 2006-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 156999
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 225
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11491851
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/491851 | Apoptosis promoters | Jul 23, 2006 | Issued |
Array
(
[id] => 102314
[patent_doc_number] => 07727982
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-06-01
[patent_title] => 'Benzamides and related inhibitors of factor Xa'
[patent_app_type] => utility
[patent_app_number] => 11/488455
[patent_app_country] => US
[patent_app_date] => 2006-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 49922
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/727/07727982.pdf
[firstpage_image] =>[orig_patent_app_number] => 11488455
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/488455 | Benzamides and related inhibitors of factor Xa | Jul 16, 2006 | Issued |
Array
(
[id] => 13794
[patent_doc_number] => 07807684
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-10-05
[patent_title] => 'HIV reverse transcriptase inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/487885
[patent_app_country] => US
[patent_app_date] => 2006-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34566
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/807/07807684.pdf
[firstpage_image] =>[orig_patent_app_number] => 11487885
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/487885 | HIV reverse transcriptase inhibitors | Jul 16, 2006 | Issued |
Array
(
[id] => 4728191
[patent_doc_number] => 20080207735
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-28
[patent_title] => '1-Amino Linked Compounds'
[patent_app_type] => utility
[patent_app_number] => 11/996128
[patent_app_country] => US
[patent_app_date] => 2006-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26201
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0207/20080207735.pdf
[firstpage_image] =>[orig_patent_app_number] => 11996128
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/996128 | 1-amino linked compounds | Jul 13, 2006 | Issued |
Array
(
[id] => 4470140
[patent_doc_number] => 07943614
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-05-17
[patent_title] => 'Carboxamide compound and use of the same'
[patent_app_type] => utility
[patent_app_number] => 11/988662
[patent_app_country] => US
[patent_app_date] => 2006-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18823
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/943/07943614.pdf
[firstpage_image] =>[orig_patent_app_number] => 11988662
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/988662 | Carboxamide compound and use of the same | Jul 11, 2006 | Issued |
Array
(
[id] => 5331375
[patent_doc_number] => 20090111852
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-30
[patent_title] => 'Carboxamide Compound and Use of the Same'
[patent_app_type] => utility
[patent_app_number] => 11/988312
[patent_app_country] => US
[patent_app_date] => 2006-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13177
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0111/20090111852.pdf
[firstpage_image] =>[orig_patent_app_number] => 11988312
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/988312 | Carboxamide compound and use of the same | Jul 11, 2006 | Issued |
Array
(
[id] => 4664281
[patent_doc_number] => 20080255188
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-16
[patent_title] => 'Muscarinic Receptor Antagonists'
[patent_app_type] => utility
[patent_app_number] => 11/995433
[patent_app_country] => US
[patent_app_date] => 2006-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14145
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0255/20080255188.pdf
[firstpage_image] =>[orig_patent_app_number] => 11995433
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/995433 | Muscarinic Receptor Antagonists | Jul 10, 2006 | Abandoned |
Array
(
[id] => 4639574
[patent_doc_number] => 08017601
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-09-13
[patent_title] => 'Bis-aryl kinase inhibitors and method'
[patent_app_type] => utility
[patent_app_number] => 11/479187
[patent_app_country] => US
[patent_app_date] => 2006-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29664
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/017/08017601.pdf
[firstpage_image] =>[orig_patent_app_number] => 11479187
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/479187 | Bis-aryl kinase inhibitors and method | Jun 29, 2006 | Issued |
Array
(
[id] => 5304237
[patent_doc_number] => 20090298889
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-03
[patent_title] => 'PHARMACEUTICAL COMPOSITIONS CONTAINING 2-PYRIDONE DERIVATIVES AS EFFECTIVE COMPONENTS'
[patent_app_type] => utility
[patent_app_number] => 11/917262
[patent_app_country] => US
[patent_app_date] => 2006-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 15040
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0298/20090298889.pdf
[firstpage_image] =>[orig_patent_app_number] => 11917262
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/917262 | PHARMACEUTICAL COMPOSITIONS CONTAINING 2-PYRIDONE DERIVATIVES AS EFFECTIVE COMPONENTS | Jun 29, 2006 | Abandoned |
Array
(
[id] => 5142514
[patent_doc_number] => 20070004730
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-04
[patent_title] => 'Amino-5-(6-membered)heteroarylimidazolone compounds and the use thereof for beta-secretase modulation'
[patent_app_type] => utility
[patent_app_number] => 11/478098
[patent_app_country] => US
[patent_app_date] => 2006-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16707
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20070004730.pdf
[firstpage_image] =>[orig_patent_app_number] => 11478098
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/478098 | Amino-5-(6-membered)heteroarylimidazolone compounds and the use thereof for β-secretase modulation | Jun 28, 2006 | Issued |
Array
(
[id] => 131920
[patent_doc_number] => 07700620
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-04-20
[patent_title] => 'C-linked cyclic antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions'
[patent_app_type] => utility
[patent_app_number] => 11/474899
[patent_app_country] => US
[patent_app_date] => 2006-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36205
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/700/07700620.pdf
[firstpage_image] =>[orig_patent_app_number] => 11474899
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/474899 | C-linked cyclic antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions | Jun 25, 2006 | Issued |
Array
(
[id] => 892303
[patent_doc_number] => 07345064
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-03-18
[patent_title] => 'TNF-α production inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/472603
[patent_app_country] => US
[patent_app_date] => 2006-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25985
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/345/07345064.pdf
[firstpage_image] =>[orig_patent_app_number] => 11472603
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/472603 | TNF-α production inhibitors | Jun 21, 2006 | Issued |
Array
(
[id] => 133077
[patent_doc_number] => 07696235
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-04-13
[patent_title] => 'EP2 receptor agonists for treating glaucoma'
[patent_app_type] => utility
[patent_app_number] => 11/472145
[patent_app_country] => US
[patent_app_date] => 2006-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 3345
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/696/07696235.pdf
[firstpage_image] =>[orig_patent_app_number] => 11472145
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/472145 | EP2 receptor agonists for treating glaucoma | Jun 20, 2006 | Issued |
Array
(
[id] => 4553307
[patent_doc_number] => 07820663
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-10-26
[patent_title] => 'Substituted enaminones, their derivatives and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/455228
[patent_app_country] => US
[patent_app_date] => 2006-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15530
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/820/07820663.pdf
[firstpage_image] =>[orig_patent_app_number] => 11455228
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/455228 | Substituted enaminones, their derivatives and uses thereof | Jun 14, 2006 | Issued |
Array
(
[id] => 569977
[patent_doc_number] => 07462634
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-12-09
[patent_title] => 'N-(pyridin-2-yl)-sulfonamide derivatives'
[patent_app_type] => utility
[patent_app_number] => 11/455065
[patent_app_country] => US
[patent_app_date] => 2006-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18790
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/462/07462634.pdf
[firstpage_image] =>[orig_patent_app_number] => 11455065
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/455065 | N-(pyridin-2-yl)-sulfonamide derivatives | Jun 14, 2006 | Issued |
Array
(
[id] => 4728151
[patent_doc_number] => 20080207695
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-28
[patent_title] => 'Thrombin Inhibiting 2-Oxo-1,2,5,6-Tetrahydropyridine Derivatives'
[patent_app_type] => utility
[patent_app_number] => 11/917515
[patent_app_country] => US
[patent_app_date] => 2006-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21654
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0207/20080207695.pdf
[firstpage_image] =>[orig_patent_app_number] => 11917515
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/917515 | Thrombin Inhibiting 2-Oxo-1,2,5,6-Tetrahydropyridine Derivatives | Jun 13, 2006 | Abandoned |
Array
(
[id] => 7801259
[patent_doc_number] => 08129531
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-03-06
[patent_title] => 'Process of producing bleach boosters'
[patent_app_type] => utility
[patent_app_number] => 11/917217
[patent_app_country] => US
[patent_app_date] => 2006-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8627
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/129/08129531.pdf
[firstpage_image] =>[orig_patent_app_number] => 11917217
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/917217 | Process of producing bleach boosters | Jun 13, 2006 | Issued |